Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Development of Human iPSC-based Microphysiogical Models of Transthyretin Amyloid Cardiomyopathy.
Journal: Research square
Published: June 22, 2026
Effect of Vutrisiran According to Baseline Tafamidis Use in Transthyretin Amyloidosis With Cardiomyopathy: Insights From HELIOS-B.
Journal: Journal of the American College of Cardiology
Published: June 22, 2026
Transthyretin Amyloid Cardiomyopathy in Women: Epidemiology, Diagnostic Delay, and Clinical Implications.
Journal: Cardiology and therapy
Published: June 03, 2026
Lessons from ATTR-CM clinical trials: Progress, persistent disparities, and emerging treatment dilemmas.
Journal: Progress in cardiovascular diseases
Published: May 29, 2026
Clinical and imaging profiling of restrictive cardiomyopathies: insights into amyloid, sarcoid, and iron overload phenotypes.
Journal: Heart failure reviews
Published: February 12, 2026
Redefining Disease Progression in ATTR-CM: Beyond Biomarkers to Patient-Centered Outcomes.
Journal: Journal of cardiac failure
Published: January 29, 2026
If You Build It, They Will Come: Early Career Reflections on Developing a Clinical Niche.
Journal: Journal of cardiac failure
Published: December 08, 2025
A comparison of single versus combination mechanism treatment for transthyretin amyloid cardiomyopathy.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: October 14, 2025
Disease Prognosis and Progression in Transthyretin Amyloidosis: JACC: CardioOncology State-of-the-Art Review.
Journal: JACC. CardioOncology
Published: August 29, 2025
Last Updated: 09/26/2026